- Home
- ALEC vs SENS Comparison
ALEC vs SENS Comparison
Compare ALEC & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | SENS |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.7M | 308.5M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ALEC | SENS |
|---|---|---|
| Price | $2.01 | $6.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $4.83 | ★ $22.70 |
| AVG Volume (30 Days) | ★ 718.7K | 505.2K |
| Earning Date | 05-07-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $21,045,000.00 | $16,389,000.00 |
| Revenue This Year | $18.36 | $70.20 |
| Revenue Next Year | N/A | $59.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $0.87 | $0.41 |
| 52 Week High | $3.40 | $8.75 |
Technical Indicators
Market Signals| Indicator | ALEC | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 44.64 | 46.07 |
| Support Level | $1.87 | $5.41 |
| Resistance Level | $2.02 | $6.87 |
| Average True Range (ATR) | 0.14 | 0.39 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 7.38 | 72.56 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.